Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant
08:10pm, Thursday, 30'th Jul 2020
Selective Estrogen Receptor Degrader in Phase III Trial For Use in Resistant ER-Positive Breast CancerREDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today
Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for
04:33pm, Thursday, 30'th Jul 2020
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Personalis: Buy This Disruptor In Precision Medicine And Machine Learning
09:00am, Monday, 27'th Jul 2020
Company's proprietary NeXT platform is a precision medicine and machine learning analytics platform that helps pharma companies develop new compounds tailored for each patient.
$10,000 Invested in These Growth Stocks Could Make You a Fortune
11:08am, Sunday, 26'th Jul 2020
If you've got $10,000 to invest and can stomach high levels of volatility, here are three growth stocks that could make you a fast fortune. The company focuses on two related markets -- content deliv
Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 22'nd Jul 2020
Is (GH) Outperforming Other Medical Stocks This Year?
Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020
12:05pm, Tuesday, 21'st Jul 2020
REDWOOD CITY, Calif., July 21, 2020 -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the second quarter 2020 after market close on.
Got $5,000? 3 Brilliant Stocks to Buy Right Now | The Motley Fool
11:03am, Sunday, 19'th Jul 2020
They're growing fast and have fantastic long-term prospects.
CENTRAL TRUST Co Buys 1,303 Shares of Guardant Health Inc (NASDAQ:GH)
05:06am, Saturday, 18'th Jul 2020
CENTRAL TRUST Co boosted its position in shares of Guardant Health Inc (NASDAQ:GH) by 904.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fu
How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market
12:00pm, Friday, 17'th Jul 2020
Genetics stocks like Guardant Health and Exact Sciences are launching new genetic tests for cancer that help find cancer earlier and tailor treatments.
Why Guardant Health (GH) is an Incredible Growth Stock?
05:12pm, Monday, 13'th Jul 2020
Baron Asset Fund recently published its second-quarter commentary – a copy of which can be downloaded here. During the second quarter of 2020, the Baron Asset Fund returned 28.02% (institutional sha
Baron Funds Q2 2020 Andrew Peck Letter
12:10pm, Monday, 13'th Jul 2020
Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing.
Did Hedge Funds Make The Right Call On Guardant Health, Inc. (GH)?
11:37pm, Sunday, 12'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Mount Yale Investment Advisors LLC Takes Position in Guardant Health Inc (NASDAQ:GH)
07:10am, Sunday, 12'th Jul 2020
Mount Yale Investment Advisors LLC purchased a new stake in shares of Guardant Health Inc (NASDAQ:GH) in the second quarter, Holdings Channel.com reports. The firm purchased 2,809 shares of the compan
ClearBridge Aggressive Growth Strategy Portfolio Manager Commentary Q2 2020
06:20pm, Saturday, 11'th Jul 2020
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
